Resultats de la cerca - GF Rosal

  • Mostrar 1 - 2 resultats de 2
Refinar resultats
  1. 1
    Secukinumab Provides Higher Symptomatic Improvement Versus Adalimumab in Psoriatic Arthritis: Comparative Effectiveness Up to 48 Weeks Assessed by two Matching-Adjusted indirect Comparisons

    Secukinumab Provides Higher Symptomatic Improvement Versus Adalimumab in Psoriatic Arthritis: Comparative Effectiveness Up to 48 Weeks Assessed by two Matching-Adjusted indirect Co... per Howard Thom, Matthias Hünger, GF Rosal, Kunal K. Gandhi, SM Jugl, Peter Nash

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data

    Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Cli... per Walter P. Maksymowych, Jessica A. Walsh, Howard Thom, Chrysostomos Kalyvas, GF Rosal, Brian Porter, Kunal K. Gandhi, SM Jugl

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: